| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 716951 | Null | 0.0414190425892865 | 0.41876463 |
| NSC 720299 | Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane | 0.0414190425892865 | 0.41834166 |
| NSC 720386 | Methyl-12.alpha.-acetoxy-5.beta.cholan-24-oate-3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane | 0.0414190425892865 | 0.20269094 |
| NSC 722781 | trans-bis(acetato)amminepyridineplatinum(II) | 0.0414190425892865 | 0.27836237 |
| NSC 728035 | 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di | 0.0414190425892865 | 0.12728892 |
| NSC 730868 | (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one | 0.0414190425892865 | 0.27366932 |
| NSC 737231 | Null | 0.0414190425892865 | 0.31106862 |
| NSC 740 | Methotrexate | 0.0414190425892865 | 0.32772365 |
| NSC 743876 | Null | 0.0414190425892865 | 0.38019853 |
| NSC 744063 | Null | 0.0414190425892865 | 0.36780039 |